Context. Fertility control appears as a publicly acceptable alternative to lethal methods for limiting population growth in wildlife. Recently developed single-dose immunocontraceptive vaccines have induced infertility in several mammals. However, the potential side-effects and the long-term effectiveness of these contraceptives have been poorly investigated.
Introduction
Current trends of landscape development and human population growth suggest that human-wildlife conflicts, often associated with overabundant or expanding animal populations, are likely to increase in the near future (Messmer 2009; White and Ward 2010) . Traditional methods employed to mitigate these conflicts, such as culling or toxicants, can be inefficient in the long term, environmentally hazardous and may compromise animal welfare (Waddell et al. 2001; Delsink et al. 2006; Massei et al. 2010a) . At the same time, growing public antipathy towards lethal control places increasing constraints on management options, particularly for species that have a high public profile (Barr et al. 2002; Deigert et al. 2003; Thornton and Quinn 2009) . Translocation of problem animals is often advocated as a humane alternative to culling. However, translocations are expensive, may have negative effects on animal welfare, can be responsible for introduction of pathogens and may not provide long-term solutions (Massei et al. 2010a) . Conversely, fertility control has the potential to offer a long-term, effective and humane means of reducing the size and growth of overabundant wildlife populations (Fagerstone et al. 2002; Rutberg and Naugle 2008) . Increasing numbers of theoretical and empirical models on the effects of fertility control on population dynamics of wildlife suggest that this approach could be as effective as or even more effective than culling to reduce population size (Hobbs et al. 2000; Merrill et al. 2003; Bradford and Hobbs 2008) . Theoretical models also predict that fertility control could play a significant role in disease management when used alongside vaccination: for instance, immunocontraception added to rabies vaccination could improve rabies control campaigns by reducing the proportion of the population that must be treated, or by reducing the duration of the vaccination campaign (Smith and Cheeseman 2002; Ramsey 2007; Carroll et al. 2010; Massei in press) .
A contraceptive suitable for field applications in wildlife management (Fagerstone et al. 2010; Gionfriddo et al. 2011) should: (1) render a high proportion of animals infertile for several years after administration of a single dose, (2) have nil or minimal negative side-effects, (3) target preferentially females but ideally be also effective on males, (4) be relatively inexpensive, and (5) be available as an oral formulation. Recently developed, single-dose immunocontraceptives meet most of these criteria, although these compounds are currently available only as injectable formulations.
Immunocontraceptive vaccines act by inducing antibodies against proteins or hormones essential for reproduction (Delves 2002) . The gonadotropin-releasing hormone (GnRH) peptide used in GnRH immunocontraceptives is secreted by the hypothalamus of the brain and stimulates the secretion of luteinising and follicle-stimulating hormones by the anterior pituitary gland . These hormones, in turn, activate hormone and gamete production by the ovary and by the testis. GnRH-based immunocontraceptives cause the production of GnRH antibodies, thus preventing the production of sex hormones and ultimately inhibiting ovulation and spermatogenesis. Several GnRH-based immunocontraceptive vaccines have been developed and tested on many species of mammals, including humans. Most of these vaccines, designed for livestock and companion animals, are administered in multiple doses (reviewed in McLaughlin and Aitken 2010) and, as such, they are unsuitable for wildlife applications. However, single-dose GnRH-based injectable vaccines appear more promising for wildlife management (Fagerstone et al. 2002; Kirkpatrick et al. 2011) . Among these, the single-dose injectable GnRH vaccine GonaConÔ was found to cause infertility for 1-5 years in many species of mammals (e.g. Miller et al. 2000 Miller et al. , 2008b Killian et al. 2008a; Massei et al. 2008; Gray et al. 2010) .
Few studies have investigated the duration of induced infertility in conjunction with the potential long-term sideeffects of GonaConÔ on physiology and behaviour. A study carried out by Massei et al. (2008) on captive female wild boar established that GonaConÔ had rendered all treated sows (n = 6) infertile for at least one year and that in the four months following vaccination GonaConÔ had had no effect on the behaviour and on the haematological and biochemical variables of the sows (n = 12 treated and 12 controls), although treated females had greater bodyweight than controls. However, if fertility control is going to be used to manage populations of long-lived animals, such as wild boar and other ungulates, the potential side-effects and long-term effectiveness of a contraceptive must be assessed. Evaluating the long-term effectiveness of a contraceptive is needed to predict the effects of fertility control, in terms of proportion of infertile animals and longevity of effect, on population size. For territorial or hierarchically structured species, contraception-induced changes in social behaviour, such as decreased aggressiveness, could lead to disruption of social hierarchies and spacing behaviour and, in turn, affect the impact of fertility control on a population (Saunders et al. 2002; Crawford et al. 2011) . The potential impact of a contraceptive on social behaviour should thus be evaluated before fertility control is used to manage wildlife populations.
This study expanded the work initiated by Massei et al. (2008) and aimed at evaluating the long-term effectiveness and potential side-effects of GonaConÔ on physiology and behaviour of captive female wild boar. Wild boar was used as a model species because of its worldwide distribution, as native or introduced species, and its impact on human interests. The latter include damage to crops and livestock, spread of diseases, vehicle collisions and reduction in plant and animal abundance and richness (e.g. Hone 2002; Engeman et al. 2004; Massei and Genov 2004; Conover 2007) . Although the species can be controlled through hunting (Massei et al. 2011) , it is essential to evaluate different options to manage overabundant populations, particularly in urban and/or protected areas where culling is unfeasible or undesirable.
Materials and methods
The study was conducted in two trials, Trial 1 and Trial 2, between 2004 and 2010.
In 2004, 2-year-old wild boar females (n = 12) of proven fertility were obtained from a local farm and housed as a single group in three interconnected outdoor paddocks (each 77 Â 24 m). Animals were fed on commercial pig diet, offered ad libitum water and equipped with coloured ear-tags for individual identification. Six females were unexpectedly found to be pregnant and births occurred in early July. All the piglets were removed by a veterinarian within 3 days of birth. On 17 August 2004 females were randomly assigned to Treatment group (n = 6) and injected intramuscularly in the rump with 1000 mg of GonaCon, or to Control group (n = 6) and injected with the adjuvant only. Each group comprised 3 previously pregnant and 3 non-pregnant females. Trial 2 was designed to replicate Trial 1 and to monitor the effects of GonaConÔ on the reproductive cycle of wild boar. On 26 April 2006 new female wild boar were randomly assigned to the Treatment (n = 6) or Control group (n = 6), as in Trial 1. Controls in Trial 2 were injected with a saline solution only as Trial 1 had shown that the adjuvant had no obvious adverse injection site reaction (Massei et al. 2008) . In both trials, the vaccine contained the mollusc protein Keyhole limpet hemocyanin as a carrier.
Two males were introduced with the sows of Trial 1 In June 2007 one male was introduced for three months with the sows of Trial 2. After births had occurred, all piglets were removed. In January 2010 the male boar normally housed with the females in Trial 1 was introduced again for three months with the sows of Trial 2.
Effectiveness of GonaConÔ to induce long-term infertility
The effectiveness of the vaccine to maintain infertility was determined by collecting the following data: (1) immune response to the vaccine, assessed by measuring serum antibodies to the GnRH, (2) concentration of faecal progesterone used as an indicator of cycling, and (3) reproductive output.
Blood samples were collected from all sows under anaesthesia at vaccination, 6 and 12 weeks after vaccination and thereafter every 6-9 months. Animals were anaesthetised by a mixture of Zoletil ® (tiletamine-zolazepam), Zalopine ® (medetomidine hydrochloride) and Torbugesic ® (butorphanol tartrate) administered by dart gun. The enzyme-linked immunosorbent assay (ELISA) was used to measure anti-GnRH antibody titres. Fifty microlitres of wild boar serum were used for each assay. A 96-well plate was prepared by adding 100 ng of Bovine Serum Albumin (BSA)-GnRH antigen to each well and then blocking with SeaBlock from Pierce Chemical. Antibodies to GnRH in the wild boar serum were detected by placing a BSA-GnRH on the ELISA plate. Wild boar serum was serially diluted from 1 : 1000 to 1 : 128 000 in phosphate-buffered saline containing SeaBlock. Antibodies in the wild boar serum to GnRH on the plate were detected with the following linkages: rabbit anti-wild boar IgG, bound to the wild boar IgG, and horseradish peroxidase (HRP)-goat anti-rabbit bound to the rabbit IgG. Chromogen tetramethylbenzidine was used to develop the colour, and 2 M H 2 SO 4 was used to stop the reaction. The colour intensity of the sample was read at 450 nm with a Dynatech MR 5000 ELISA plate and expressed as an absorbance value. Anti-GnRH antibody titres were calculated by comparing blood samples between preand postvaccination, and expressed as the highest dilution (i.e. 1 : 16 000, 1 : 32 000 or 1 : 64 000) in which the postvaccination sample had a higher absorbance value than that of the prevaccination sample.
Samples with titres higher than 1 : 128 000 were rerun with serial dilution from 1 : 4000 to 1 : 512 000.
During the wild boar breeding season, between 23 November and 17 December 2009, faecal samples were collected by staff who followed individual animals until the faecal sample was produced. Samples were collected twice a week from all females of Trial 2 and then processed as described in Massei et al. (2008) . A fully validated ELISA was used to measure the concentration of progesterone as described in Massei et al. (2008) .
Reproductive output was assessed by the number of females giving birth. Differences in the proportions of treated and control animals pregnant at the end of the study, in 2010, were analysed by Fisher's Exact Test. Bodyweight was recorded every 6-9 months in parallel with blood collection for antibody titres.
Effects of GonaConÔ on behaviour and physiology
To determine whether vaccination with GonaConÔ affected the social rank of wild boar, behavioural data on agonistic interactions with trial mates were collected as described in Massei et al. (2008) and compared between trials and before and after vaccination. In Trial 1 prevaccination was in July In brief, the behaviour of each animal was observed in 3-h sessions carried out once or twice every fortnight and the identity of the animal initiating or receiving an agonistic interaction was noted. The Barrette and Vandal (1986) index on agonistic interactions (AI) was derived for each animal as follows:
A REML analysis was carried out on the AI indices to test for the effect of trial, treatment (treated versus control) and vaccination period (before and after vaccination).
Differences in bodyweight between groups were analysed by an Analysis of Covariance (ANCOVA). Data were log 10 -transformed and the initial weight, recorded at vaccination, was used as covariate.
A general blood chemistry panel was performed on blood samples by Carmichael Torrance Diagnostic Services Ltd (Leeds, UK). For each sample, the following biochemical parameters were collected: a-, b-and gamma-globulins, ionised calcium, albumin, urea, creatinine, alkaline phosphatase, aspartate aminotransferase, gamma-glutamyl transferase, sodium, potassium, calcium and bile acids. The following haematological parameters were also collected: haemoglobin, packed cell volume, red blood cell count, white blood cell count, mean corpuscular volume, mean corpuscular haemoglobin concentration, neutrophils and lymphocytes. Data from the last collection date were used to compare biochemical and haematological values of treated and control females. In October 2009, the following animals were sampled: four treated sows in Trial 1, 62 months after vaccination, and 12 sows in Trial 2 (n = 6 treated and 6 controls) 42 months after vaccination. Differences in haematological and biochemical values between treated and control animals were analysed with a Multivariate Analysis of Variance (MANOVA). Data analyses were carried out in GENSTAT 13 (Payne 2003) .
The study was carried out under a UK Home Office licence, in accordance with the Animals (Scientific Procedures) Act 1986 and was approved by the Food and Environment Research Agency's Ethical Review Process.
Results

Effectiveness of GonaConÔ to induce long-term infertility
Two treated animals in Trial 1 died under anaesthesia, one in July 2007 and one in October 2009, for causes believed to be unrelated to the vaccine. The analysis of GnRH antibody titres showed a long-term, sustained immune response in both groups of treated wild boar (Fig. 1) . Notably, after an initial drop in the 12-24 months following vaccination, antibody titres stayed relatively but consistently low (1 : 64 000) in subsequent years and were associated with infertility in 11 out of 12 treated animals (see below). Antibodies were not measured in control animals as these sows were not expected to have anti-GnRH titres.
The results on progesterone levels indicated that in all 6 control and in 2 treated females in Trial 2 progesterone peaked from 100-500 ng g -1 during the follicular phase preceding ovulation to 8000-15 000 ng g -1 during the luteal phase following ovulation (Table 1) . The GnRH antibody titres of the two treated animals that appeared to cycle (PuPu and RG), measured 1 : 32 000 whereas the titres of all the other wild boar were !1 : 64 000. In all the other four treated females progesterone levels varied between 67 and 1761 ng g -1 . In October 2007 all control females in Trial 2 and one treated female (PuPu) gave birth. In May-June 2010, five control females in Trial 2 and the same treated female (PuPu) gave birth to 5-7 piglets per litter. The control that did not give birth (YPu) was cycling like the other controls but had dry blood around the genital area at the end of May 2010, suggesting that she might have aborted a litter. The other treated female (RG) that was cycling and had relatively low antibody titres did not give birth. In summary, in 2010, 4-6 years after treatment with GonaConÔ, nine out of the 10 treated females were still infertile and at least 5 out of 6 control females gave birth. The difference in reproductive output between treated and control was significant (Fishers's Test P = 0.008).
Effects of GonaConÔ on behaviour and physiology
The Agonistic Interaction index varied with treatment (c 2 = 48.85, d.f. = 1, P < 0.001) but not with trial (c 2 = 3.56, d.f. = 1, P = 0.06), vaccination period (c 2 = 2.48, d.f. = 34, P = 1), treatment*trial (c 2 = 0.35, d.f. = 1, P = 0.55) and treatment*vaccination period (c 2 = 21.35, d.f. = 34, P = 0.95). For ease of presentation, the AI indices were converted to social ranks (Fig. 2) derived by calculating an AI for each animal on each day and by ranking the AIs from 1 to 12, with 12 indicating the highest social rank. The results of the analysis indicated that animals in treated groups had initially higher AI indices than controls but that vaccination had no effect on aggressiveness as both groups of animals maintained their ranks throughout the trials.
Bodyweight increased with time in both groups. In Trial 2, the bodyweight of treated and control females did not differ (F 1,59 < 1.0, P = 0.665) up to 54 months after vaccination (Fig. 3) .
There were no differences between GonaConÔ-treated and control wild boar in biochemical (Wilk's statistic = 0.0896, F 14,1 = 0.726, P = 0.740) or haematological (Wilk's statistic = 0.8722, F 9,6 = 0.098, P = 0.999) variables (Table 2) . No signs of lameness were noticed in treated animals in the years following vaccination and no obvious granulomata or abscesses were recorded at the injection site when animals were examined under anaesthesia by a veterinarian during regular health checks.
Discussion
Our study showed that a single dose of GonaConÔ induced infertility for at least 3-6 years in 11 out of 12 female wild boar. This contraceptive prevented treated animals from cycling but did not affect their physiology and behaviour, thus confirming earlier results (Massei et al. 2008) . Treatment with GonaConÔ did not affect aggressiveness; the difference between trials was borderline significant (P = 0.06) and might have been due to small sample size. In addition, the temporary bodyweight increase in treated females observed three months after vaccination (Massei et al. 2008 ) did not persist: at the end of this study, four years after vaccination, the bodyweight of treated animals in Trial 2 did not differ from that of controls. The results on progesterone levels indicated that all six control and two treated females in Trial 2 were cycling although only one of these treated females gave birth. This was consistent with other studies; for instance, white-tailed deer treated with a single-shot Porcine Zona Pellucida immunocontraceptive that showed signs of breeding behaviour and increased progesterone levels indicating oestrous did not become pregnant in the following season ).
Similarly, in deer treated with GonaConÔ the reproductive behaviour occurred 1-2 years before the animals became fertile again . A possible explanation is that follicular development and the production of oestrogen are sufficient to support reproductive behaviour but inadequate to restore fertility ). This study tested simultaneously the effectiveness and the potential side-effects of a contraceptive on wild boar over 4-6 years. Most studies carried out on single-dose immunocontraceptives in wildlife focussed either on effectiveness (e.g. Miller et al. 2008b; Killian et al. 2008a; Gray et al. 2010) or on potential side-effects (e.g. Kirkpatrick and Turner 2007; Curtis et al. 2008; Gionfriddo et al. 2011; Yoder and Miller 2011) . Results from other studies indicate that the long-term effectiveness of GonaConÔ, in terms of both duration of infertility and proportion of animals rendered infertile, varies in relation to species and possibly health condition of the animals. For instance, a single injection of GonaConÔ administered to females rendered 100% (n = 6) of bison (Bison bison) and feral pigs (n = 9) infertile for at least a year Killian et al. 2006a ), 91% of California ground squirrels (Spermophilus beecheyi) infertile in Year 1 (n = 33) and Year 2 (n = 24) after vaccination (Nash et al. 2004 ) and 100% (n = 10) of elk (Cervus elaphus) infertile for 3 years ). Long-term studies showed that GnRH antibody titres decrease with time and that reproduction may resume in some animals in the years following vaccination. Some of these studies suggested that the effectiveness of GonaconÔ, measured as the proportion of individuals rendered infertile, was greater in captivity than in field trials. For instance GonaConÔ caused infertility in 80% (n = 5) of captive white-tailed deer (Odocoileus virginianus) for five years ) but a subsequent study carried out with freeliving animals (Gionfriddo et al. 2009 ) reported infertility in 88% and 47% of the deer (n = 28) during the first and second year after vaccination. Similarly, in captive wild horses GonaConÔ caused infertility in 94%, 60% and 53% of the mares (n = 15) in Year 1, 2 and 3 following vaccination ) but in freeroaming feral horses GonaConÔ caused infertility in 39%, 42% and 31% of the mares (Gray et al. 2010 ). These differences might be due to the possibility that the better body conditions, usually found in captive animals, might affect immunocompetence and hence the strength and persistence of the immune response to the vaccine (Gray et al. 2010) . Differences in immune response to vaccines might also be due to species, age, sex, reproductive status (pregnant versus non-pregnant animals), genetic variation in populations and exposure to other antigens (e.g. Buehler et al. 2011; Demas et al. 2011) . Understanding the role these factors play in shaping an individual's response to immunocontraception will assist to optimise fertility control applications in terms of candidate species, timing of treatment and context. For instance, if pregnancy were found to affect immunocompetence, animals could be treated before the reproductive peak; likewise, animals might be vaccinated outside seasonal food shortages that might affect their health and thus their immune response. Field trials with free-living wild boar should be conducted to determine whether the results found in this study can be replicated in field conditions. Several studies found no side-effects of GonaConÔ on the physiology and behaviour of animals treated with GonaConÔ. For instance, GonaConÔ did not affect bodyweight or blood chemistry of black-tailed prairie dogs (Cynomys ludovicianus) (Yoder and Miller 2011) and blood chemistry in white-tailed deer (Killian et al. 2006b) . However, other studies in whitetailed deer, cats and elk reported that animals treated with GonaConÔ developed palpable non-painful injection site granulomata or sterile abscesses that did not seem to affect the welfare of the animals (Killian et al. 2006b; Curtis et al. 2008; Gionfriddo et al. 2009; Levy et al. 2011) . The granuloma at the injection site plays a prime role in the host's defence against the 'chronic infection' represented by a multiyear immunocontraceptive and is considered necessary to the efficacy of the adjuvant . As all methods employed in wildlife management to decrease population size have advantages and disadvantages (e.g. Massei et al. 2011) , the occurrence and potential implications of side-effects must be viewed against alternative options to contraception such as lethal control.
The results of this study confirmed that injectable GonaConÔ met the safety and effectiveness criteria required for an ideal fertility control agent. For wildlife applications, an oral immunocontraceptive would be preferable to an injectable one as it would eliminate the costs of trapping and handling animals. However, as GnRH is widely conserved among mammals, it is likely that an oral formulation could affect non-target species (Levy 2011) . Thus an oral GnRH vaccine would require the use of a species-specific delivery system, such as those developed to deliver pharmaceuticals to wild pigs (Long et al. 2010; Massei et al. 2010b ).
In the current injectable formulation, immunocontraceptives can have a variety of field applications in situations where culling is not feasible, desirable or legal. These include control of overabundant wildlife in urban areas and parks, iconic species for which culling is publicly unacceptable, and protected areas where hunting is not allowed. Other applications of these immunocontraceptives concern instances when population size reduction is required for disease control, particularly when alternative options, such as culling, have the potential for social perturbation. Several authors highlighted that culling can affect social behaviour and lead to increased disease transmission whilst fertility control is unlikely to have similar effects (e.g. Smith and Cheeseman 2002; McDonald et al. 2008; Killian et al. 2009; Harrison et al. 2010) . In addition, fertility control can induce behavioural changes, such as reproductionrelated long-distance movements, that reduce disease transmission rates (e.g. Caley and Ramsey 2001; Ramsey et al. 2002; Ramsey 2007) .
GonaConÔ is currently registered in the US as a contraceptive for white-tailed deer (Fagerstone et al. 2010) . Whilst many traditional forms of intervention are subject to increasing public criticism, the longevity, safety and social acceptability of this immunocontraceptive for managing overabundant wildlife offer a credible alternative to lethal control. Field trials are now needed to test the feasibility, effectiveness and costs of managing free-living populations through fertility control based on immunocontraception.
